摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5E)-5-{[5-(2,5-Dichlorophenyl)-2-furyl]methylene}-3-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-YL)-2-thioxo-1,3-thiazolidin-4-one | 324544-20-9

中文名称
——
中文别名
——
英文名称
(5E)-5-{[5-(2,5-Dichlorophenyl)-2-furyl]methylene}-3-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-YL)-2-thioxo-1,3-thiazolidin-4-one
英文别名
(5E)-5-[[5-(2,5-dichlorophenyl)furan-2-yl]methylidene]-3-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-2-sulfanylidene-1,3-thiazolidin-4-one
(5E)-5-{[5-(2,5-Dichlorophenyl)-2-furyl]methylene}-3-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-YL)-2-thioxo-1,3-thiazolidin-4-one化学式
CAS
324544-20-9
化学式
C25H17Cl2N3O3S2
mdl
——
分子量
542.5
InChiKey
SWQCENWRANLNCT-FYJGNVAPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.8
  • 重原子数:
    35
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    114
  • 氢给体数:
    0
  • 氢受体数:
    6

文献信息

  • NOVEL RHODANINE DERIVATIVES, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF AIDS CONTAINING THE RHODANINE DERIVATIVES AS ACTIVE INGREDIENTS
    申请人:Avixgen Inc.
    公开号:EP2583969A2
    公开(公告)日:2013-04-24
    Disclosed are novel rhodanine derivatives which are inhibitory of HIV activity. Also provided are a method for preparing the novel rhodanine derivatives, and a pharmaceutical composition for the prevention or treatment of AIDS containing the rhodanine derivatives as active ingredients. Having high inhibitory activity against HIV, the rhodanine derivatives can be effectively used in the prophylaxis or therapy of AIDS.
    揭示了一种新颖的罗丹宁生物,对HIV活性具有抑制作用。还提供了一种制备这种新颖罗丹宁生物的方法,以及一种含有罗丹宁生物作为活性成分的用于预防或治疗艾滋病的药物组合物。罗丹宁生物对HIV具有高抑制活性,可以有效用于艾滋病的预防或治疗。
  • NOVEL RHODANINE DERIVATIVES, METHOD FOR PREPARING SAME, AND PAHRMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF AIDS CONTAINING THE RHODANINE DERIVATIVES AS ACTIVE INGREDIENTS
    申请人:You Ji Chang
    公开号:US20130096125A1
    公开(公告)日:2013-04-18
    Disclosed are novel rhodanine derivatives which are inhibitory of HIV activity. Also provided are a method for preparing the novel rhodanine derivatives, and a pharmaceutical composition for the prevention or treatment of AIDS containing the rhodanine derivatives as active ingredients. Having high inhibitory activity against HIV, the rhodanine derivatives can be effectively used in the prophylaxis or therapy of AIDS.
    揭示了一种新颖的罗丹宁生物,对HIV活性具有抑制作用。还提供了一种制备这种新颖罗丹宁生物的方法,以及一种包含罗丹宁生物作为活性成分的用于预防或治疗艾滋病的药物组合物。罗丹宁生物对HIV具有高抑制活性,可以有效用于艾滋病的预防或治疗。
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING OSTEOARTHRITIS, CONTAINING RHODANINE DERIVATIVE AS ACTIVE INGREDIENT
    申请人:Avixgen Inc.
    公开号:EP3827827A1
    公开(公告)日:2021-06-02
    The present disclosure relates to the use of a rhodanine derivative in the prevention, amelioration or treatment of osteoarthritis. The rhodanine derivative according to the present disclosure has excellent effects of rescuing the loss of the cartilage matrix and alleviating synovitis, and thus may be effectively used for the prevention, amelioration or treatment of osteoarthritis.
    本公开涉及一种罗丹宁生物在预防、改善或治疗骨关节炎中的用途。根据本公开的罗丹宁生物在挽救软骨基质的损失和缓解滑膜炎方面具有极佳的效果,因此可有效地用于预防、改善或治疗骨关节炎。
  • US8759536B2
    申请人:——
    公开号:US8759536B2
    公开(公告)日:2014-06-24
  • [EN] PHARMACEUTICAL COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING OSTEOARTHRITIS, CONTAINING RHODANINE DERIVATIVE AS ACTIVE INGREDIENT<br/>[FR] COMPOSITION PHARMACEUTIQUE PERMETTANT DE PRÉVENIR, DE SOULAGER OU DE TRAITER L'ARTHROSE CONTENANT UN DÉRIVÉ DE RHODANINE EN TANT QUE PRINCIPE ACTIF<br/>[KO] 로다닌 유도체를 유효성분으로 포함하는 골관절염 예방, 개선 또는 치료용 약학적 조성물
    申请人:AVIXGEN INC
    公开号:WO2020022789A1
    公开(公告)日:2020-01-30
    본 발명은 로다닌 유도체의 골관절염 예방, 개선 또는 치료 용도에 관한 것으로, 본 발명에 따른 로다닌 유도체는 연골 기질의 손실을 회복시키고 활맥막염을 완화시키는 효과가 우수하므로, 골관절염의 예방, 개선 또는 치료에 유용하게 활용할 수 있다.
查看更多